Boiron SA (EPA: BOI)

France flag France · Delayed Price · Currency is EUR
25.30
+0.05 (0.20%)
Jan 20, 2025, 5:35 PM CET
-39.73%
Market Cap 439.27M
Revenue (ttm) 481.71M
Net Income (ttm) 23.69M
Shares Out 17.36M
EPS (ttm) 1.36
PE Ratio 18.54
Forward PE 22.32
Dividend 1.35 (5.35%)
Ex-Dividend Date n/a
Volume 2,000
Average Volume 2,834
Open 25.10
Previous Close 25.25
Day's Range 25.10 - 26.05
52-Week Range 24.80 - 42.80
Beta 0.45
RSI 44.25
Earnings Date Mar 20, 2025

About Boiron

Boiron SA manufactures and sells homeopathic medicines in France, rest of Europe, North America, and internationally. The company offers non-proprietary homeopathic medicines and homeopathic specialties; and other healthcare products include medical devices, invitro diagnostics, dietary supplements, cosmetics, and phytotherapy. It also provides homeopathic specialties comprising Oscillococcinum to treat influenza symptoms, such as fever, chills, headaches, and aches; Stodal and Stodaline for treating coughs; Arnigel for adjunctive local treatme... [Read more]

Sector Healthcare
Founded 1932
Employees 2,810
Stock Exchange Euronext Paris
Ticker Symbol BOI
Full Company Profile

Financial Performance

In 2023, Boiron's revenue was 493.25 million, a decrease of -7.67% compared to the previous year's 534.24 million. Earnings were 35.83 million, a decrease of -19.80%.

Financial Statements

News

There is no news available yet.